Search

Your search keyword '"Kim, Sung Bae"' showing total 11 results
Start Over Author "Kim, Sung Bae" Journal scientific reports
11 results on '"Kim, Sung Bae"'

1. Longitudinal dynamics of circulating tumor DNA for treatment monitoring in patients with breast cancer recurrence

Author

Yoo, Tae-Kyung Robyn, Lee, Ji-Young, Park, Hwan, Cho, Whi-Kyung, Jeon, Seyeon, Jun, Ha Ra, Lee, Sae Byul, Chung, Il Yong, Kim, Hee Jeong, Ko, Beom Seok, Lee, Jong Won, Son, Byung Ho, Ahn, Sei-Hyun, Jeong, Jae Ho, Kim, Jeong Eun, Ahn, Jin-Hee, Jung, Kyung Hae, Kim, Sung-Bae, Lee, Hee Jin, Gong, Gyungyub, Kim, Jisun, and Chun, Sung-Min

Published
2024
Full Text
View/download PDF

5. Publisher Correction: Analysis of the serial circulating tumor cell count during neoadjuvant chemotherapy in breast cancer patients

Author

Gwark, Sungchan, Kim, Jisun, Kwon, Nak-Jung, Kim, Kyoung-Yeon, Kim, YongNam, Lee, Cham Han, Kim, Young Hun, Kim, Myoung Shin, Hong, Sung Woo, Choi, Mi Young, Jeon, Byung Hee, Chang, Suhwan, Yu, Jonghan, Park, Ji Yeon, Lee, Hee Jin, Lee, Sae Byul, Chung, Il Yong, Ko, Beom Seok, Kim, Hee Jeong, Lee, Jong Won, Son, Byung Ho, Ahn, Jin-Hee, Jung, Kyung Hae, Kim, Sung-Bae, Gong, Gyung-Yub, and Ahn, Sei Hyun

Published
2021
Full Text
View/download PDF

7. Analysis of the serial circulating tumor cell count during neoadjuvant chemotherapy in breast cancer patients

Author

Gwark, Sungchan, Kim, Jisun, Kwon, Nak-Jung, Kim, Kyoung-Yeon, Kim, YongNam, Lee, Cham Han, Kim, Young Hun, Kim, Myoung Shin, Hong, Sung Woo, Choi, Mi Young, Jeon, Byung Hee, Chang, Suhwan, Yu, Jonghan, Park, Ji Yeon, Lee, Hee Jin, Lee, Sae Byul, Chung, Il Yong, Ko, Beom Seok, Kim, Hee Jeong, Lee, Jong Won, Son, Byung Ho, Ahn, Jin-Hee, Jung, Kyung Hae, Kim, Sung-Bae, Gong, Gyung-Yub, and Ahn, Sei Hyun

Published
2020
Full Text
View/download PDF

10. Association between tumor 18F-fluorodeoxyglucose metabolism and survival in women with estrogen receptor-positive, HER2-negative breast cancer.

Author

Chae, Sun Young, Park, Seol Hoon, Lee, Hyo Sang, Ahn, Jin-Hee, Kim, Sung-Bae, Jung, Kyung Hae, Kim, Jeong Eun, Ahn, Sei Hyun, Son, Byung Ho, Lee, Jong Won, Ko, Beom Seok, Kim, Hee Jeong, Gong, Gyungyub, Oh, Jungsu S., Park, Seo Young, and Moon, Dae Hyuk

Subjects
POSITRON emission tomography, BREAST cancer, COMPUTED tomography, ESTROGEN receptors, NEOADJUVANT chemotherapy
Abstract

We examined whether 18F-fluorodeoxyglucose metabolism is associated with distant relapse-free survival (DRFS) and overall survival (OS) in women with estrogen receptor (ER)-positive, HER2-negative breast cancer. This was a cohort study examining the risk factors for survival that had occurred at the start of the study. A cohort from Asan Medical Center, Korea, recruited between November 2007 and December 2014, was included. Patients received anthracycline-based neoadjuvant chemotherapy. The maximum standardized uptake value (SUV) of 18F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) was measured. The analysis included 466 women. The median (interquartile range) follow-up period without distant metastasis or death was 6.2 (5.3–7.6) years. Multivariable analysis of hazard ratio (95% confidence interval [CI]) showed that the middle and high tertiles of SUV were prognostic for DRFS (2.93, 95% CI 1.62–5.30; P < 0.001) and OS (4.87, 95% CI 1.94–12.26; P < 0.001). The 8-year DRFS rates were 90.7% (95% CI 85.5–96.1%) for those in the low tertile of maximum SUV vs. 73.7% (95% CI 68.0–79.8%) for those in the middle and high tertiles of maximum SUV. 18F-fluorodeoxyglucose PET/CT may assess the risk of distant metastasis and death in ER-positive, HER2-negative patients. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results